ANNA CLUSKEY: Open Payments
NPI 1316508617 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,768 in 132 payments from 22 companies in 2025. Trend: 2023 $9,699 · 2024 $4,535 · 2025 $6,768
Food & beverage: $3,633Consulting: $2,921Speaker / faculty: $200Education: $14
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $1,558 |
| Janssen Biotech, Inc. | 2 | $1,375 |
| EMD Serono, Inc. | 21 | $951 |
| Novartis Pharmaceuticals Corporation | 23 | $499 |
| Biogen, Inc. | 14 | $490 |
| Alexion Pharmaceuticals, Inc. | 5 | $307 |
| TG Therapeutics, Inc. | 5 | $298 |
| UCB, Inc. | 3 | $234 |
| Amgen Inc. | 6 | $199 |
| ABBVIE INC. | 12 | $182 |
Products named: KESIMPTA, BRIUMVI, ULTOMIRIS, Zilbrysq, TYSABRI, UPLIZNA, UBRELVY, Mavenclad.
Industry payments across WI — which companies pay providers there.
